These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9328197)

  • 1. Incidence and mortality of neuroblastoma in Canada compared with other childhood cancers.
    Gao RN; Levy IG; Woods WG; Coombs BA; Gaudette LA; Hill GB
    Cancer Causes Control; 1997 Sep; 8(5):745-54. PubMed ID: 9328197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroblastoma: changing incidence and survival in young people aged 0-24 years. A report from the North of England Young Persons' Malignant Disease Registry.
    Cotterill SJ; Parker L; More L; Craft AW
    Med Pediatr Oncol; 2001 Jan; 36(1):231-4. PubMed ID: 11464892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening of infants and mortality due to neuroblastoma.
    Woods WG; Gao RN; Shuster JJ; Robison LL; Bernstein M; Weitzman S; Bunin G; Levy I; Brossard J; Dougherty G; Tuchman M; Lemieux B
    N Engl J Med; 2002 Apr; 346(14):1041-6. PubMed ID: 11932470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Improved survival in children with neuroblastoma].
    Schrøder H; Wacher J; Larsson H; Rosthøj S; Rechnitzer C; Petersen BL; Carlsen NL
    Ugeskr Laeger; 2010 Oct; 172(40):2761-5. PubMed ID: 20926047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the Cessation of Mass Screening for Neuroblastoma at 6 Months of Age: A Population-Based Study in Osaka, Japan.
    Ioka A; Inoue M; Yoneda A; Nakamura T; Hara J; Hashii Y; Sakata N; Yamato K; Tsukuma H; Kawa K
    J Epidemiol; 2016; 26(4):179-84. PubMed ID: 26548355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroblastoma trends in Osaka, Japan, and Great Britain 1970-1994, in relation to screening.
    Honjo S; Doran HE; Stiller CA; Ajiki W; Tsukuma H; Oshima A; Coleman MP
    Int J Cancer; 2003 Feb; 103(4):538-43. PubMed ID: 12478672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of mass screening for neuroblastoma on incidence, mortality, and survival rates in Osaka, Japan.
    Ajiki W; Tsukuma H; Oshima A; Kawa K
    Cancer Causes Control; 1998 Dec; 9(6):631-6. PubMed ID: 10189049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divergent Patterns of Incidence in Peripheral Neuroblastic Tumors.
    Merrihew LE; Fisher PG; Effinger KE
    J Pediatr Hematol Oncol; 2015 Oct; 37(7):502-6. PubMed ID: 26133942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for neuroblastoma is ineffective in reducing the incidence of unfavourable advanced stage disease in older children.
    Woods WG; Tuchman M; Robison LL; Bernstein M; Leclerc JM; Brisson LC; Brossard J; Hill G; Shuster J; Luepker R; Byrne T; Weitzman S; Bunin G; Lemieux B; Brodeur GM
    Eur J Cancer; 1997 Oct; 33(12):2106-12. PubMed ID: 9516863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of neuroblastoma: analysis of a single institution.
    Izbicki T; Mazur J; Izbicka E
    Anticancer Res; 2003; 23(2C):1933-8. PubMed ID: 12820482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Childhood cancer incidence in Canada: demographic and geographic variation of temporal trends (1992-2010).
    Xie L; Onysko J; Morrison H
    Health Promot Chronic Dis Prev Can; 2018 Mar; 38(3):79-115. PubMed ID: 29537768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroblastoma incidence and survival in European children (1978-1997): report from the Automated Childhood Cancer Information System project.
    Spix C; Pastore G; Sankila R; Stiller CA; Steliarova-Foucher E
    Eur J Cancer; 2006 Sep; 42(13):2081-91. PubMed ID: 16919772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International variations in the incidence of neuroblastoma.
    Stiller CA; Parkin DM
    Int J Cancer; 1992 Oct; 52(4):538-43. PubMed ID: 1399133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A population-based study of the usefulness of screening for neuroblastoma.
    Woods WG; Tuchman M; Robison LL; Bernstein M; Leclerc JM; Brisson LC; Brossard J; Hill G; Shuster J; Luepker R; Byrne T; Weitzman S; Bunin G; Lemieux B
    Lancet; 1996 Dec 21-28; 348(9043):1682-7. PubMed ID: 8973429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent incidences and trends of childhood malignant solid tumors in Shanghai, 2002-2010].
    Bao PP; Li K; Wu CX; Huang ZZ; Wang CF; Xiang YM; Peng P; Gong YM; Xiao XM; Zheng Y
    Zhonghua Er Ke Za Zhi; 2013 Apr; 51(4):288-94. PubMed ID: 23927803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in neuroblastoma in Great Britain: incidence and mortality, 1971-1990.
    Stiller CA
    Eur J Cancer; 1993; 29A(7):1008-12. PubMed ID: 8499132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of mass screening on age-specific incidence of neuroblastoma.
    Bessho F
    Int J Cancer; 1996 Aug; 67(4):520-2. PubMed ID: 8759611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A population-based study of neuroblastoma incidence, survival, and mortality in North America.
    Bernstein ML; Leclerc JM; Bunin G; Brisson L; Robison L; Shuster J; Byrne T; Gregory D; Hill G; Dougherty G
    J Clin Oncol; 1992 Feb; 10(2):323-9. PubMed ID: 1732433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence and mortality rates of neuroblastoma cases before and after the cessation of the mass screening program in Japan: A descriptive study.
    Shinagawa T; Kitamura T; Katanoda K; Matsuda T; Ito Y; Sobue T
    Int J Cancer; 2017 Feb; 140(3):618-625. PubMed ID: 27778323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.